SEC Form D · filed January 15, 2021
Sage Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (31)
Jeffrey M. Jonas · Cambridge, MAExec · DirectorKevin P. Starr · Cambridge, MADirectorBarry Greene · Cambridge, MAExec · DirectorKimi Iguchi · Cambridge, MAExecStephen J. Kanes · Cambridge, MAExecElizabeth F. Barrett · Cambridge, MADirectorGeno F. Germano · Cambridge, MADirectorGeorge F. Golumbeski · Cambridge, MADirectorSteven F. Paul · Cambridge, MADirectorBrandon Arvanaghi · Miami Beach, FLDirectorThomas E. Zanecchia · Denver, CODirectorMatt Munson · Marina del Rey, CAExec · DirectorMichael F. Cola · Wayne, PADirectorMichael Cloonan · Cambridge, MAExecAnne Marie Cook · Cambridge, MAExecAlbert J. Robichaud · Cambridge, MAExecJames F. Frates · Cambridge, MADirectorMichael Neagle · Dallas, TXExec · DirectorJohn Mattes · Dallas, TXDirectorKrishnakanth S. Nimmagadda · McKinney, TXDirectorBarry Greene · Cambridge, MAExec · DirectorKimi Iguchi · Cambridge, MAExecMichael Cloonan · Cambridge, MAExecAnne Marie Cook · Cambridge, MAExecStephen J. Kanes · Cambridge, MAExecAlbert J. Robichaud · Cambridge, MAExecElizabeth F. Barrett · Cambridge, MADirectorJames F. Frates · Cambridge, MADirectorGeno F. Germano · Cambridge, MADirectorGeorge F. Golumbeski · Cambridge, MADirectorMichael F. Cola · Wayne, PADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗